Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: PROTEÍNAS QUINASES, DOR, FARMACOLOGIA
ABNT
SACHS, Daniela et al. The role of PKA and PKC'épsilon' pathways in prostaglandin 'E IND.2'-mediated hypernociception. British Journal of Pharmacology, v. 156, n. 5, p. 826-834, 2009Tradução . . Acesso em: 18 ago. 2024.APA
Sachs, D., Villarreal, C. F., Cunha, F. de Q., Parada, C. A., & Ferreira, S. H. (2009). The role of PKA and PKC'épsilon' pathways in prostaglandin 'E IND.2'-mediated hypernociception. British Journal of Pharmacology, 156( 5), 826-834.NLM
Sachs D, Villarreal CF, Cunha F de Q, Parada CA, Ferreira SH. The role of PKA and PKC'épsilon' pathways in prostaglandin 'E IND.2'-mediated hypernociception. British Journal of Pharmacology. 2009 ; 156( 5): 826-834.[citado 2024 ago. 18 ]Vancouver
Sachs D, Villarreal CF, Cunha F de Q, Parada CA, Ferreira SH. The role of PKA and PKC'épsilon' pathways in prostaglandin 'E IND.2'-mediated hypernociception. British Journal of Pharmacology. 2009 ; 156( 5): 826-834.[citado 2024 ago. 18 ]